Ray Therapeutics and Forge Biologics Expand Their Viral Vector cGMP Partnership to Encompass Plasmid DNA Manufacturing
Building on AAV manufacturing partnership with new plasmid production, Forge’s end-to-end manufacturing services will help to advance Ray Therapeutics’ gene therapy for patients living with retinitis pigmentosa and other blinding diseases SAN FRANCISCO, CALIFORNIA AND COLUMBUS, OHIO October 10, 2022 – Ray Therapeutics, a biotechnology company developing optogenetic gene therapies for patients with retinal degenerative […]
Ray Therapeutics Appoints Dr. Peter Francis as Chief Scientific & Medical Officer and Jenny Holt as SVP, Program Portfolio Management
September 06, 2022 08:00 AM Eastern Daylight Time SAN FRANCISCO–(BUSINESS WIRE)–Ray Therapeutics, a biotech company whose mission is to restore vision to patients with blinding eye diseases, today announced the appointment of Peter Francis, M.D., Ph.D., as Chief Scientific & Medical Officer, and Jenny Holt as Senior Vice President, Program Portfolio Management. Dr. Francis is […]
Ray Therapeutics Receives $4M in Funding From the California Institute for Regenerative Medicine (CIRM)
– Funding will Advance Development of Ray Therapeutics’ Optogenetics Technology Platform – Company will Advance Ray-001 for the Treatment of Retinitis Pigmentosa SAN DIEGO–(BUSINESS WIRE)– Ray Therapeutics, a biotechnology company developing optogenetic gene therapies for patients with retinal degenerative conditions, announced today that the California Institute for Regenerative Medicine (CIRM) has awarded the company a […]
Ray Therapeutics and Forge Biologics Announce Viral Vector Contract Development and cGMP Manufacturing Partnership
Posted on March 1, 2022 (March 1, 2022) by Forge Biologics SAN DIEGO, CALIFORNIA AND COLUMBUS, OHIO March 1, 2022 – Ray Therapeutics, a biotechnology company developing optogenetic gene therapies for patients with retinal degenerative conditions, and Forge Biologics, a gene therapy-focused contract development and manufacturing organization, announced a manufacturing partnership that will advance Ray Therapeutics’ lead optogenetics gene therapy […]